Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-16$66.30/sh+37,000$2,453,100→ 37,000 totalExercise: $66.30Exp: 2034-01-15→ Common Stock (37,000 underlying) - Award
Common Stock
2024-01-16+25,445→ 58,376.37 total
Footnotes (2)
- [F1]This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
- [F2]This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.